Specific activation of sodium iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA)

Anticancer Research

Volumn 29, Issue 1, 2009, Pages 211-221

  Liu, Ren Shyan ^a,c,d   Hsieh, Ya Ju ^b,c   Ke, Chien Chih ^a,c   Chen, Fu Du ^b   Hwu, Luen ^c   Wang, Fu Hui ^c   Hwang, Jeng Jong ^a   Chi, Chin Wen ^a,d   Lee, Chen Hsen ^a,d   Yeh, Shin Hwa ^a,c,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c NRPGM   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Alpha fetoprotein (AFP); Hepatitis B virus enhancer (EIIAPA); Hepatocellular carcinoma; Sodium iodine symporter (NIS)

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B VIRUS ENHANCER II PROTEIN; IODINE 124; SODIUM IODIDE SYMPORTER; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENHANCER REGION; GENE; GENE EXPRESSION REGULATION; GENE TRANSFER; HEPATITIS B VIRUS; HNIS GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; RADIOIODINATION;

ALPHA-FETOPROTEINS; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; ENHANCER ELEMENTS, GENETIC; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS B VIRUS; HUMANS; IODINE RADIOISOTOPES; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; PROMOTER REGIONS, GENETIC; SYMPORTERS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 61449187540     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Feitelson MA, Sun B, Satiroglu Tufan NL, Liu J, Pan J and Lian Z: Genetic mechanisms of hepatocarcinogenesis. Oncogene 21: 2593-2604, 2002.
2. Bruix J, Sala M and Llovet JM: Chemoembolization for hepatocellular carcinoma. Gastroenterology 127: S179-S188, 2004.
3. Omata M, Tateishi R, Yoshida H and Shiina S: Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation. Gastroenterology 127: S159-S166, 2004.
4. Jolesz FA, Hynynen K, McDannold N, Freundlich D and Kopelman D: Noninvasive thermal ablation of hepatocellular carcinoma using magnetic resonance imaging-guided focused ultrasound. Gastroenterology 127: S242-S247, 2004.
5. Llovet JM and Beaugr M: Hepatocellular carcinoma: present status and future prospects. J Hepat 38: 136-149, 2003.
6. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A and Gennari L: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 693-699, 1996.
7. Wiesner RH, Freeman RB and Mulligan DC: Liver transplant for hepatocellular cancer. The impact of the MELD allocation policy. Gastroenterology 127: S261-S268, 2004.
8. Carlin S, Cunningham SH, Boyd M, McCluskey AG and Mairs RJ: Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two- and three-dimensional models. Cancer Gene Ther 7: 1529-1536, 2000.
9. Nakamura Y, Ohtaki S and Yamazaki I: Molecular mechanism of iodide transport by thyroid plasmalemmal vesicles: cooperative sodium activation and asymmetrical affinities for the ions on the outside and inside of the vesicles. J Biochem 104: 544-549, 1988.
10. Arturi F, Russo D, Schlumberger M, du Villard JA, Caillou B, Vigneri P, Wicker R, Chiefari E, Suarez HG and Filetti S: Iodide symporter gene expression in human thyroid tumors. J Clin Endocrinol Metab 83: 2493-2496, 1998.
11. Lazar V, Bidart JM, Caillou B, Mahé C, Lacroix L, Filetti S and Schlumberger M: Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab 84: 3228-3234, 1999.
12. Min JJ, Chung JK, Lee YJ, Jeong JM, Lee DS, Jang JJ, Lee MC and Cho BY: Relationship between expression of the sodium/iodide symporter and 1311 uptake in recurrent lesions of differentiated thyroid carcinoma. Eur J Nucl Med 28: 639-645, 2001.
13. Haberkorn U, Henze M, Altmann A, Jiang S, Morr I, Mahmut M, Peschke P, Kubier W, Debus J and Eisenhut M: Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells. J Nucl Med 42: 317-325, 2001.
14. Boland A, Ricard M, Opolon P, Bidart JM, Yen P, Filetti S, Schlumberger M and Perricaudet M: Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res 60: 3484-3492, 2000.
15. Cho JY, Shen DH, Yang W, Williams B, Buckwalter TL, La Perle KM, Hinkle G, Pozderac R, Kloos R, Nagaraja HN, Barth RF and Jhiang SM: In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas. Gene Ther 9: 1139-1145, 2002.
16. Kogai T, Taki K and Brent GA: Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. Endocr Relat Cancer 13: 797-826, 2006.
17. Dwyer RM, Schatz SM, Bergert ER, Myers RM, Harvey ME, Classic KL, Blanco MC, Frisk CS, Marier RJ, Davis BJ, O'Connor MK, Russell SJ and Morris JC: A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancer. Mol Ther 12: 835-841, 2005.
18. Cho JY: A transporter gene (sodium iodide symporter) for dual purposes in gene therapy: imaging and therapy. Curr Gene Ther 2: 393-402, 2002.
19. Kanai F: Transcriptional targeted gene therapy for hepatocellular carcinoma by adenovirus vector. Mol Biotechnol 18: 243-250, 2001.
20. Beasley RP, Hwang LY, Lin CC and Chien CS: Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 2: 1129-1133, 1981.
21. Guo WT, Bell KD and Ou JH: Characterization of the hepatitis B virus EnhI enhancer and X promoter complex. J Virol 65: 6686-6692, 1991.
22. Shaul Y, Rutter WJ and Laub O: A human hepatitis B viral enhancer element. EMBO J 4: 427-430, 1985.
23. Trulillo MA, Letovsky J, Maguire HF, Lopez-Cabrera M and Siddiqui A: Functional analysis of a liver-specific enhancer of the hepatitis B virus. Proc Natl Acad Sci USA 88: 3797-3801, 1991.
24. Guo W, Chen M, Yen TS and Ou JH: Hepatocyte-specific expression of the hepatitis B virus core promoter depends on both positive and negative regulation. Mol Cell Biol 13: 443-448, 1993.
25. Lopez-Cabrera M, Letovsky J, Hu KQ and Siddiqui A: Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus. Virology 183: 825-829, 1991.
26. Weiss SJ, Philp NJ and Grollman EF: Iodide transport in a continuous line of cultured cells from rat thyroid. Endocrinology 114: 1090-1098, 1984.
27. Hsieh YJ, Liu RS, Hwu L, Ke CC, Wang FH, Wang HE and Chen FD: Cre/loxP System controlled by specific promoter for radiation-mediated gene therapy on hepatoma. Anticancer Res 27: 1571-1580, 2007.
28. Dai G, Levy O and Carrasco N: Cloning and characterization of the thyroid iodide transporter. Nature 379: 458-460, 1996.
29. Smanik PA, Liu Q, Furminger TL, Ryu K, Xing S, Mazzaferri EL and Jhiang SM: Cloning of the human sodium iodide symporter. Biochem and Biophys Res Commun 226: 339-345, 1996.
30. Kang JH, Chung JK, Lee YJ, Shin JH, Jeong JM, Lee DS and Lee MC: Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy. J Nucl Med 45: 1571-1576, 2004.
31. - symporter as an imaging reporter gene. J Nucl Med 47: 182-190, 2006.
32. Su H, Lu R, Chang JC and Kan YW: Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice. PNAS 94: 13891-13896, 1997.
33. Willhauck MJ, Sharif Samani BR, Klutz K, Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R, Goke B, Morris JC and Spitzweg C: Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma. Gene Ther 15: 214-23, 2008.
34. Mawatari F, Tsuruta S, Ido A, Ueki T, Nakao K, Kato Y, Tamaoki T, Ishii N and Nakata K: Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter. Cancer Gene Ther 5: 301-306, 1998.
35. Ishikawa H, Nakata K, Mawatari F, Ueki T, Tsuruta S, Ido A, Nakao K, Kato Y, Ishii N and Eguchi K: Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma. Gene Ther 6: 465-470, 1999.
36. Gilbert S, Galarneau L, Lamontagne A, Roy S and Belanger L: The hepatitis B virus core promoter is strongly activated by the liver nuclear receptor fetoprotein transcription factor or by ectopically expressed steroidogenic factor 1. J Virol 74: 5032-5039, 2000.
37. Ishida H, Ueda K, Ohkawa K, Kanazawa Y, Hosui A, Nakanishi F, Mita E, Kasahara A, Sasaki Y, Hori M and Hayashi N: Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II. J Virol 74: 1241-1251, 2000.
38. Verma IM and Somia N: Gene therapy: promises, problems and prospects. Nature 389: 239-242, 1997.
39. Follenzi A, Sabatino G, Lombarde A, Boccaccio C and Naldini L: Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. Hum Gene Ther 13: 243-260, 2002.
40. Kafri T, Blomer U, Peterson DA, Gage FH and Verma IM: Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 17: 314-317, 1997.
41. Pellinen R, Hakkarainen T, Wahlfors T, Tuilimaki K, Ketola A, Tenhunen T, Salonen T and Wahlfors J: Cancer cells as targets for lentivirus-mediated gene transfer and gene therapy. Int J Oncol 25: 1753-1762, 2004.
42. Dingli D, Diaz RM, Bergert ER, O'Connor MK, Morris JC and Russell SJ: Genetically targeted radiotherapy for multiple myeloma. Blood 102: 489-496, 2003.
43. Zhang B, Zhang Y, Wang J, Zhang Y, Chen J, Pan Y, Ren L, Hu Z, Zhao J, Liao M and Wang S: Screening and identification of a targeting peptide to hepatocarcinoma from a phage display peptide library. Mol Med 13: 246-254, 2007.